|
Stage I germ cell tumors
Stage I
seminomas: These cancers are cured in more than 95% of
patients. They are first treated by surgically removing the testicle
and spermatic cord (radical inguinal orchiectomy). After surgery,
several choices exist:
Radiation therapy: Radiation
aimed at regional lymph nodes (inguinal and retroperitoneal lymph
nodes) is the most common next step. Because seminoma cells are very
sensitive to radiation, low doses can be used, usually for about 10 to
15 treatments.
The doctor may recommend
radiation therapy even though CT scan results do not show that the
cancer has spread to the nodes. This is because in about 1 in 5
patients, cancerous cells have spread, but cannot be seen on imaging
tests like CT scans. Radiation therapy is usually successful in
destroying these hidden (occult) metastases.
Chemotherapy:
Another choice that works as well as radiation is to give 1 or 2 doses
of chemotherapy with the drug carboplatin after surgery.
Careful observation
(surveillance): Another approach to treating men with
stage I seminomas is to not give radiation or chemotherapy right after
surgery, but instead to watch patients closely for a few years. This
means seeing the doctor and getting a physical exam, blood tests and
imaging studies (chest x-rays and CT scans) every few months for the
several years, then possibly less frequently after that. If these tests
do not find any signs that cancer has spread beyond the testicle, no
additional treatment will be given. About 15% to 20% of patients will
relapse, but if metastasis is detected later, radiation or chemotherapy
can still be used effectively to cure the cancer.
One way doctors decide
whether or not to treat is based on the size of the tumor and whether
it invades nearby blood vessels. If the tumor is large or invades blood
vessels, they may recommend treatment with either radiation or
chemotherapy.
Stage I
non-seminomas: These cancers are also highly curable
(about 98%), but the standard treatment is different from that of
seminomas. As with seminomas, the initial treatment is surgery to
remove the testicle and tumor (radical inguinal orchiectomy). Then the
treatment choices depend on the stage.
For stage IA (T1) there are 2 choices:
- Retroperitoneal
lymph node dissection (RPLND): This has the advantage of a
high cure rate but the disadvantages of major surgery, with its
complications and possibly losing the ability to ejaculate normally.
After RPLND, if the nodes are found to have cancer in them,
chemotherapy may be recommended depending on how much cancer is found.
- Careful
observation (surveillance) for several years: The
advantage of surveillance is that there are no problems with surgery or
chemotherapy side effects. The disadvantage is that you have to see the
doctor a lot and get lots of x-rays and tests. For the first 2 years,
the doctor visits and blood tests are every 1 to 2 months, and the CT
scans are every 2 to 4 months. Without careful watching the cancer can
come back (relapse) and can grow so large that it may not be curable.
So far, this has not happened in men who saw their doctor for follow-up
visits as scheduled. Most relapses occur in the first year after
diagnosis, with most of the rest in the second year. Relapses are
generally treated with chemotherapy. Even though more patients will
have a relapse with surveillance than with lymph node dissection, the
cure rates are similar for both approaches because the relapses are
usually found early enough to be cured.
For stage IB (T2, T3, or T4) there are up to 3 options:
- Retroperitoneal
lymph node dissection: As in stage IA, chemotherapy may be
recommended after RPLND depending on the extent of cancer found.
- Careful
observation (surveillance): This requires frequent doctor
visits and tests for several years. This is usually not an option if
the tumor is T3 or T4 or for T2 disease that has vascular invasion
(something seen by the pathologist looking at the tumor under the
microscope).
- Chemotherapy:
The most common option is the BEP regimen for 2
cycles. This option has a high cure rate but has the disadvantage of
the side effects of chemotherapy (mostly the short-term effects, since
2 cycles cause fewer long-term effects).
For stage in situ (is):
If the tumor marker levels
(like AFP or HCG) are still high even after the testicle/tumor is
removed, but no tumor is seen on a CT scan, full-dose chemotherapy is
recommended for 3 to 4 cycles.
Doctors have learned that certain features of the tumor mean
that the cancer might come back. These depend on the blood test results
and the way the cancer cells look under the microscope. If these
features are present, doctors are less likely to recommend observation
only.
Stage II germ cell tumors
Stage II
seminomas: These cancers are treated differently depending
on the size of the retroperitoneal lymph nodes.
Stages IIa and IIb:
In these stages the lymph nodes are not larger than 5 cm. These cancers
are treated with surgery to remove the testicle (radical inguinal
orchiectomy), followed by radiation to the retroperitoneal lymph nodes.
Usually higher doses of radiation are given for stage II seminomas than
for stage I seminomas. If radiation can't be given for some reason,
chemotherapy may be used instead.
Stage IIc: In this
stage, the lymph nodes are larger than 5 cm. These cancers are treated
with radical inguinal orchiectomy, followed by 3 or 4 cycles of
chemotherapy. Radiotherapy is generally not used for stage IIc
seminoma.
Stage II
non-seminomas: Treatment for these tumors depends on the
tumor markers and the retroperitoneal lymph nodes. All men will have
radical inguinal orchiectomy to remove the testicle with the tumor.
After surgery, there are 2 main options:
Retroperitoneal lymph node
dissection (RPLND). This may be followed by further
treatment with chemotherapy if the lymph nodes have cancer in them.
Chemotherapy is usually given for 2 cycles.
Chemotherapy.
Sometimes the doctor will recommend that the patient go straight to
chemotherapy (without doing the RPLND surgery). This is more likely to
happen if the retroperitoneal lymph nodes are very large on the CT scan
or if the tumor marker levels (HCG and/or AFP) are high even after the
testicle with the tumor is removed. The chemotherapy is usually given
for 3 or 4 cycles.
After chemotherapy, a CT scan is repeated to see if the
retroperitoneal lymph nodes are still enlarged. If they are, they are
removed by RPLND.
Stage III germ cell tumors
Both stage III seminomas and non-seminomas are treated with
orchiectomy followed by 3 or 4 cycles of chemotherapy with a
combination of drugs. The main regimens are the same as those used for
stage II testicular cancers (usually BEP or EP). This treatment
produces a cure in over 70% of cases.
Once chemotherapy is complete, the doctor looks for any cancer
that remains. Patients with normal scans and normal markers are usually
watched carefully after this and may need no further treatment.
Sometimes a few tumors may remain. These are most often in the
lung or in the retroperitoneal lymph nodes. Further treatment at this
point depends on the type of cancer.
Seminomas:
Tumors that remain after chemotherapy but do not seem to still be
growing are often observed with imaging tests. Results of the PET scan
and the size of the tumor will influence the decision to continue
follow-up with imaging tests and tumor markers or to consider surgery
and/or radiation therapy. Chemotherapy with different drugs may be an
option if these treatments don't work.
Non-seminomas:
Residual tumors are usually removed surgically, which may result in a
cure. Further chemotherapy, but with different drugs, may also be an
option. Patients whose cancer has metastasized to the brain usually
receive chemotherapy plus radiation therapy aimed at the brain,
although surgery for the brain tumor is another option.
If the tumor marker levels are very high or the cancer is
widespread then the usual chemotherapy treatment may not always be
enough. Sometimes the doctor may recommend high-dose chemotherapy
followed by a stem cell transplant if regular chemotherapy is not
working. Patients might also want to consider enrolling in a clinical
trial of newer chemotherapy regimens (for more information, see the
section, "Clinical
trials").
Recurrent germ cell tumors
If the cancer goes away with treatment and then comes back, it
is said to have recurred or relapsed. Treatment of recurrent germ cell
tumors depends on the initial stage and treatment. Cancer that comes
back in the retroperitoneal lymph nodes can be treated by surgery
(RPLND) if the recurrence is small (and if the only surgical treatment
given before was orchiectomy). Depending on the results of the surgery,
chemotherapy may be recommended.
If it looks as if cancer has recurred in a lot of the
retroperitoneal lymph nodes or if the cancer has returned elsewhere,
then chemotherapy is usually recommended. This may be followed by
surgery.
If a man's cancer recurs after chemotherapy or if his
treatment is no longer working, he will be treated with different
chemotherapy regimens, which typically include ifosfamide, cisplatin,
and either etoposide, paclitaxel, or vinblastine.
The treatment of testicular cancer that has come back after
chemotherapy is not always as effective as doctors would like.
Therefore, some doctors may advise high-dose chemotherapy followed by a
stem cell transplant. This may be a better option for men with
recurrent disease, rather than standard chemotherapy. (See the section,
"High-dose
chemotherapy and stem cell transplant" for more information.)
In general, if chemotherapy is no longer working, it is
probably best to get a second opinion from a center of excellence with
extensive experience in treating relapsed testicular cancer patients,
before starting other treatments. Clinical trials can also be
considered.
Sertoli cell and Leydig cell tumors
Radical inguinal orchiectomy is usually recommended for
Sertoli cell and Leydig cell tumors. Radiation therapy and chemotherapy
are generally not effective in these rare types of testicular tumors.
If the doctor suspects the tumor has metastasized beyond the testicle,
the retroperitoneal lymph nodes may be surgically removed.
Last Medical Review: 08/03/2009 Last Revised: 08/03/2009
|